Biogen Historical Balance Sheet

BIIB Stock

USD 225.21 6.37 2.75%

Trend analysis of Biogen Inc balance sheet accounts such as Short Long Term Debt Total of 7.7 B, Other Current Liabilities of 969.8 M or Total Current Liabilities of 3.6 B provides information on Biogen's total assets, liabilities, and equity, which is the actual value of Biogen Inc to its prevalent stockholders. By breaking down trends over time using Biogen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Biogen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biogen Inc is a good buy for the upcoming year.

Biogen Inventory

2.65 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

About Biogen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biogen Inc at a specified time, usually calculated after every quarter, six months, or one year. Biogen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biogen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biogen currently owns. An asset can also be divided into two categories, current and non-current.

Biogen Balance Sheet Chart

Biogen Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biogen Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.

At present, Biogen's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 7.7 B, whereas Cash is forecasted to decline to about 723.1 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Capital Stock

Add Fundamental

Total Assets

Total assets refers to the total amount of Biogen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biogen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biogen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Capital Stock

The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.

Most accounts from Biogen's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	7.6B	6.6B	7.3B	7.7B
Total Assets	23.9B	24.6B	26.8B	28.2B

Short Long Term Debt Total Total Assets

Biogen balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments	Common Stock	Short Term Debt
Total Assets		0.92	0.67	0.95	0.94	0.96	0.85	0.99	0.63	0.99	-0.57	0.61	0.97	-0.74	0.94	0.56	-0.82	0.96	0.86	0.93	0.59	0.89	-0.8	0.3	-0.8	0.39
Short Long Term Debt Total	0.92		0.63	0.86	0.76	0.89	0.96	0.9	0.58	0.9	-0.72	0.59	0.85	-0.62	0.98	0.54	-0.92	0.97	0.8	0.87	0.45	0.83	-0.63	0.33	-0.63	0.29
Other Current Liab	0.67	0.63		0.78	0.53	0.64	0.46	0.63	0.79	0.58	-0.43	0.88	0.59	-0.67	0.69	0.45	-0.64	0.73	0.24	0.79	-0.1	0.73	-0.56	0.74	-0.56	0.44
Total Current Liabilities	0.95	0.86	0.78		0.85	0.92	0.75	0.91	0.72	0.92	-0.53	0.67	0.88	-0.74	0.89	0.45	-0.79	0.94	0.75	0.9	0.43	0.94	-0.74	0.34	-0.74	0.52
Total Stockholder Equity	0.94	0.76	0.53	0.85		0.89	0.68	0.94	0.56	0.93	-0.37	0.52	0.95	-0.73	0.78	0.54	-0.63	0.82	0.86	0.87	0.7	0.79	-0.85	0.18	-0.85	0.29
Property Plant And Equipment Net	0.96	0.89	0.64	0.92	0.89		0.82	0.92	0.59	0.96	-0.5	0.54	0.95	-0.78	0.92	0.56	-0.75	0.94	0.88	0.87	0.5	0.95	-0.78	0.21	-0.78	0.44
Net Debt	0.85	0.96	0.46	0.75	0.68	0.82		0.83	0.33	0.86	-0.7	0.38	0.78	-0.5	0.94	0.48	-0.86	0.91	0.81	0.73	0.54	0.71	-0.56	0.22	-0.56	0.22
Retained Earnings	0.99	0.9	0.63	0.91	0.94	0.92	0.83		0.63	0.97	-0.62	0.6	0.97	-0.66	0.92	0.51	-0.85	0.94	0.85	0.93	0.61	0.83	-0.73	0.28	-0.73	0.33
Cash	0.63	0.58	0.79	0.72	0.56	0.59	0.33	0.63		0.51	-0.41	0.9	0.59	-0.64	0.59	0.42	-0.6	0.64	0.3	0.83	-0.07	0.72	-0.47	0.52	-0.47	0.34
Non Current Assets Total	0.99	0.9	0.58	0.92	0.93	0.96	0.86	0.97	0.51		-0.55	0.49	0.96	-0.69	0.93	0.52	-0.78	0.95	0.91	0.86	0.67	0.86	-0.78	0.18	-0.78	0.4
Non Currrent Assets Other	-0.57	-0.72	-0.43	-0.53	-0.37	-0.5	-0.7	-0.62	-0.41	-0.55		-0.38	-0.52	0.14	-0.72	-0.2	0.87	-0.68	-0.46	-0.55	-0.26	-0.47	0.06	-0.2	0.06	-0.18
Cash And Short Term Investments	0.61	0.59	0.88	0.67	0.52	0.54	0.38	0.6	0.9	0.49	-0.38		0.53	-0.6	0.61	0.53	-0.6	0.64	0.18	0.84	-0.14	0.62	-0.55	0.83	-0.55	0.37
Net Receivables	0.97	0.85	0.59	0.88	0.95	0.95	0.78	0.97	0.59	0.96	-0.52	0.53		-0.71	0.88	0.52	-0.77	0.9	0.88	0.89	0.6	0.85	-0.75	0.18	-0.75	0.32
Common Stock Shares Outstanding	-0.74	-0.62	-0.67	-0.74	-0.73	-0.78	-0.5	-0.66	-0.64	-0.69	0.14	-0.6	-0.71		-0.64	-0.57	0.42	-0.68	-0.56	-0.75	-0.26	-0.8	0.85	-0.36	0.85	-0.28
Non Current Liabilities Total	0.94	0.98	0.69	0.89	0.78	0.92	0.94	0.92	0.59	0.93	-0.72	0.61	0.88	-0.64		0.55	-0.92	0.99	0.79	0.88	0.43	0.85	-0.65	0.37	-0.65	0.39
Other Current Assets	0.56	0.54	0.45	0.45	0.54	0.56	0.48	0.51	0.42	0.52	-0.2	0.53	0.52	-0.57	0.55		-0.34	0.53	0.43	0.6	0.19	0.51	-0.65	0.43	-0.65	0.05
Other Stockholder Equity	-0.82	-0.92	-0.64	-0.79	-0.63	-0.75	-0.86	-0.85	-0.6	-0.78	0.87	-0.6	-0.77	0.42	-0.92	-0.34		-0.9	-0.64	-0.81	-0.32	-0.71	0.37	-0.37	0.37	-0.33
Total Liab	0.96	0.97	0.73	0.94	0.82	0.94	0.91	0.94	0.64	0.95	-0.68	0.64	0.9	-0.68	0.99	0.53	-0.9		0.79	0.91	0.44	0.89	-0.69	0.37	-0.69	0.44
Property Plant And Equipment Gross	0.86	0.8	0.24	0.75	0.86	0.88	0.81	0.85	0.3	0.91	-0.46	0.18	0.88	-0.56	0.79	0.43	-0.64	0.79		0.67	0.78	0.76	-0.65	-0.17	-0.65	0.25
Total Current Assets	0.93	0.87	0.79	0.9	0.87	0.87	0.73	0.93	0.83	0.86	-0.55	0.84	0.89	-0.75	0.88	0.6	-0.81	0.91	0.67		0.35	0.85	-0.76	0.53	-0.76	0.33
Intangible Assets	0.59	0.45	-0.1	0.43	0.7	0.5	0.54	0.61	-0.07	0.67	-0.26	-0.14	0.6	-0.26	0.43	0.19	-0.32	0.44	0.78	0.35		0.32	-0.53	-0.35	-0.53	-0.08
Accounts Payable	0.89	0.83	0.73	0.94	0.79	0.95	0.71	0.83	0.72	0.86	-0.47	0.62	0.85	-0.8	0.85	0.51	-0.71	0.89	0.76	0.85	0.32		-0.71	0.25	-0.71	0.5
Common Stock Total Equity	-0.8	-0.63	-0.56	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.75	0.85	-0.65	-0.65	0.37	-0.69	-0.65	-0.76	-0.53	-0.71		-0.36	1.0	-0.22
Short Term Investments	0.3	0.33	0.74	0.34	0.18	0.21	0.22	0.28	0.52	0.18	-0.2	0.83	0.18	-0.36	0.37	0.43	-0.37	0.37	-0.17	0.53	-0.35	0.25	-0.36		-0.36	0.29
Common Stock	-0.8	-0.63	-0.56	-0.74	-0.85	-0.78	-0.56	-0.73	-0.47	-0.78	0.06	-0.55	-0.75	0.85	-0.65	-0.65	0.37	-0.69	-0.65	-0.76	-0.53	-0.71	1.0	-0.36		-0.22
Short Term Debt	0.39	0.29	0.44	0.52	0.29	0.44	0.22	0.33	0.34	0.4	-0.18	0.37	0.32	-0.28	0.39	0.05	-0.33	0.44	0.25	0.33	-0.08	0.5	-0.22	0.29	-0.22

Click cells to compare fundamentals

Biogen Account Relationship Matchups

Biogen balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Short Long Term Debt Total	6.4B	7.8B	7.6B	6.6B	7.3B	7.7B
Other Current Liab	3.4B	3.3B	3.3B	2.8B	838.4M	969.8M
Total Current Liabilities	4.9B	3.7B	4.3B	3.3B	3.4B	3.6B
Total Stockholder Equity	13.3B	10.7B	11.0B	13.4B	14.8B	15.5B
Property Plant And Equipment Net	3.7B	3.8B	3.8B	3.7B	3.7B	3.9B
Net Debt	3.5B	6.5B	5.3B	3.2B	6.3B	6.6B
Retained Earnings	16.5B	14.0B	13.9B	16.5B	17.6B	18.5B
Cash	2.9B	1.3B	2.3B	3.4B	1.0B	723.1M
Non Current Assets Total	18.9B	17.7B	16.0B	14.8B	20.0B	21.0B
Non Currrent Assets Other	(3.2B)	(1.4B)	1.9B	1.5B	284.3M	270.1M
Cash And Short Term Investments	4.5B	2.6B	3.8B	4.9B	1.0B	1.5B
Net Receivables	1.9B	1.9B	1.5B	2.1B	2.1B	2.2B
Common Stock Shares Outstanding	187.4M	161.3M	149.6M	146M	145.6M	283.0M
Liabilities And Stockholders Equity	27.2B	24.6B	23.9B	24.6B	26.8B	28.2B
Non Current Liabilities Total	9.0B	10.2B	8.6B	7.9B	8.6B	9.0B
Other Current Assets	1.2B	1.3B	1.2B	1.4B	1.2B	1.2B
Other Stockholder Equity	(3.0B)	(3.0B)	(2.8B)	(2.9B)	(2.7B)	(2.5B)
Total Liab	13.9B	13.9B	12.9B	11.2B	12.0B	12.6B
Property Plant And Equipment Gross	3.7B	3.8B	3.8B	3.7B	6.1B	6.4B
Total Current Assets	8.4B	6.9B	7.9B	9.8B	6.9B	7.2B
Accumulated Other Comprehensive Income	(135.2M)	(299M)	(106.7M)	(164.9M)	(153.7M)	(146.0M)
Intangible Assets	3.5B	3.1B	2.2B	1.9B	8.4B	8.8B
Accounts Payable	530.8M	454.9M	589.2M	491.5M	403.3M	423.5M
Short Term Investments	2.3B	1.6B	1.3B	1.5B	1.5B	0.0
Inventory	804.2M	1.1B	1.4B	1.3B	2.5B	2.7B
Other Liab	4.2B	2.4B	2.0B	1.3B	1.5B	969.6M
Other Assets	3.2B	4.2B	3.4B	1.7B	1.9B	2.0B
Long Term Debt	4.5B	7.4B	6.3B	6.3B	6.8B	7.1B
Property Plant Equipment	3.2B	3.4B	3.4B	3.3B	3.8B	2.1B
Good Will	5.8B	5.8B	5.8B	5.7B	6.2B	3.2B
Net Tangible Assets	4.1B	1.9B	2.9B	5.8B	6.7B	4.1B
Noncontrolling Interest In Consolidated Entity	(4.1M)	(14.2M)	63.5M	(9.5M)	(8.6M)	(8.1M)
Retained Earnings Total Equity	16.5B	14.0B	13.9B	16.5B	18.9B	11.5B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

WD	Walker Dunlop
MSFT	Microsoft
BAC	Bank of America

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:

How To Invest In Biogen

Details

Is Biogen Stock a good investment?

Details

What is Biogen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.

	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities

Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.011

Earnings Share

7.86

Revenue Per Share

66.688

Quarterly Revenue Growth

(0.07)

Return On Assets

0.0486

The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biogen Historical Balance Sheet

Biogen Inventory

2.65 Billion

About Biogen Balance Sheet Analysis

Biogen Balance Sheet Chart

Total Assets

Total Current Liabilities

Capital Stock

Biogen balance sheet Correlations

Biogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biogen balance sheet Accounts

Also Currently Popular

Complementary Tools for Biogen Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Retained Earnings	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Net Receivables	+ 0.97	Total Assets

Other Stockholder Equity	- 0.92	Non Current Liabilities Total
Other Stockholder Equity	- 0.92	Short Long Term Debt Total
Total Liab	- 0.9	Other Stockholder Equity
Other Stockholder Equity	- 0.86	Net Debt
Other Stockholder Equity	- 0.85	Retained Earnings
Common Stock	- 0.85	Total Stockholder Equity